RCT EVIDENCE ON TIME-IN-RANGE IN TYPE 1 DIABETES

被引：0
|
作者：
Battelino, T. [1 ]
Danne, T. [2 ]
Edelman, S. [3 ]
Choudhary, P. [4 ]
Renard, E. [5 ]
Westerbacka, J. [6 ]
Mukherjee, B. [6 ]
Picard, P. [7 ]
Pilorget, V. [8 ]
Bergenstal, R. [9 ]
机构：
[1] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[2] Childrens & Youth Hosp Bult, Diabet Ctr Children & Adolescents, Hannover, Germany
[3] Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, San Diego, CA 92161 USA
[4] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
[5] Montpellier Univ Hosp, Dept Endocrinol Diabet & Nutr, Montpellier, France
[6] Sanofi, Global Med Affairs, Paris, France
[7] IVIDATA Life Sci, Biostat, Levallois Perret, France
[8] Sanofi, R&d, Paris, France
[9] Healthpartners Inst, Int Diabet Ctr, Minneapolis, MN USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IS029 / #9
引用
收藏
页码：A11 / A12
页数：2
相关论文
共 50 条
  • [21] TIME-IN-RANGE WITHOUT AUTOMATED INSULIN DELIVERY SYSTEMS IN CHILDREN WITH TYPE 1 DIABETES BEFORE AND DURING A DIABETES SUMMER CAMP - A GLASS CEILING?
    Nagl, K.
    Bozic, I.
    Rami-Merhar, B.
    Weimann, K.
    Berger, G.
    Mader, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A186 - A186
  • [22] Association between Time-in-Range and MC in Basal Insulin-Treated People with Type 2 Diabetes
    Goldenberg, Ronald
    Aroda, Vanita R.
    Billings, Liana K.
    Donatsky, Anders Meller
    Frederiksen, Marie
    Klonoff, David C.
    Rizi, Ehsan Parvaresh
    Bergenstal, Richard M.
    DIABETES, 2021, 70
  • [23] Relationship between hemoglobin glycation index and risk of hypoglycemia in type 2 diabetes with time-in-range in target
    Lin, Bei-Si
    Liu, Zhi-Gu
    Chen, Dan-Rui
    Yang, Yan-Ling
    Yang, Dai-Zhi
    Yan, Jin-Hua
    Zeng, Long-Yi
    Yang, Xu-Bin
    Xu, Wen
    WORLD JOURNAL OF DIABETES, 2024, 15 (10)
  • [24] Twenty-Eight Days of Meal Delivery Improves Time-in-Range for People with Type 2 Diabetes
    Clark, Callahan
    Hart, Brian
    DIABETES, 2021, 70
  • [25] Association between Change in Time-in-Range and MC in Basal Insulin -Treated People with Type 2 Diabetes
    Goldenberg, Ronald
    Aroda, Vanita R.
    Billings, Liana K.
    Donatsky, Anders Meller
    Frederiksen, Marie
    Klonoff, David C.
    Rizi, Ehsan Parvaresh
    Bergenstal, Richard M.
    DIABETES, 2021, 70
  • [26] The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring
    Diaz-Soto, Gonzalo
    Bahillo-Curieses, M. Pilar
    Jimenez, Rebeca
    Nietoa, Maria de la.
    Gomez, Emilia
    Torres, Beatriz
    Lopez Gomez, Juan Jose
    de Luis, Daniel
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (07): : 465 - 471
  • [27] THE RELATIONSHIP OF HEMOGLOBIN A1C TO CGM-DERIVED TIME-IN-RANGE IN PATIENTS WITH DIABETES
    Vigersky, R.
    McMahon, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A119 - A120
  • [28] Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes Using Continuous Glucose Monitoring
    Bode, Bruce W.
    Clarke, John G.
    DIABETES, 2020, 69
  • [29] GLUCOSE TIME-IN-RANGE AFTER TYPE 1 DIABETES EDUCATION IS NOT DIFFERENT BETWEEN ADULTS USING INSULIN PUMPS AND MULTIPLE DAILY INJECTIONS
    McAuley, S.
    Vogrin, S.
    Lee, M.
    Paldus, B.
    Bach, L.
    Burt, M.
    Clarke, P.
    Cohen, N.
    Colman, P.
    de Bock, M.
    Hendrieckx, C.
    Holmes-Walker, D.
    Horsburgh, J.
    Jenkins, A.
    Kaye, J.
    Keech, A.
    Kumareswaran, K.
    MacIsaac, R.
    McCallum, R.
    Sims, C.
    Speight, J.
    Stranks, S.
    Trawley, S.
    Ward, G.
    Sundararajan, V.
    Jones, T.
    O'Neal, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A28 - A29
  • [30] Is It Time to Replace Time-in-Range with Time-in-Tight-Range? Maybe Not
    Beck, Roy W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (03) : 147 - 150
12345